NDC 60687-364

Ritonavir

Ritonavir

Ritonavir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Ritonavir.

Product ID60687-364_82824416-80a1-76bd-e053-2a91aa0ad8b5
NDC60687-364
Product TypeHuman Prescription Drug
Proprietary NameRitonavir
Generic NameRitonavir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-05-01
Marketing End Date2019-10-31
Marketing CategoryANDA / ANDA
Application NumberANDA202573
Labeler NameAmerican Health Packaging
Substance NameRITONAVIR
Active Ingredient Strength100 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN

Packaging

NDC 60687-364-25

30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-364-25) > 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-364-95)
Marketing Start Date2018-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60687-364-25 [60687036425]

Ritonavir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202573
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-01
Marketing End Date2019-10-31

NDC 60687-364-95 [60687036495]

Ritonavir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202573
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-01
Marketing End Date2019-10-31

Drug Details

Active Ingredients

IngredientStrength
RITONAVIR100 mg/1

OpenFDA Data

SPL SET ID:d80dfc02-a962-4ca2-bf0c-221e08c3dde2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 900575
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitor [EPC]
    • Protease Inhibitor [EPC]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 1A2 Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • UDP Glucuronosyltransferases Inducers [MoA]

    Medicade Reported Pricing

    60687036495 RITONAVIR 100 MG TABLET

    Pricing Unit: EA | Drug Type:

    60687036425 RITONAVIR 100 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Ritonavir" or generic name "Ritonavir"

    NDCBrand NameGeneric Name
    0054-0407RitonavirRitonavir
    31722-597RitonavirRitonavir
    60687-364RitonavirRitonavir
    60687-420RitonavirRitonavir
    65162-061RitonavirRitonavir
    65862-687RitonavirRitonavir
    68382-696RitonavirRitonavir
    70518-1086RitonavirRitonavir
    70518-1519RitonavirRitonavir
    70518-2007RitonavirRitonavir
    0074-1940NorvirRitonavir
    0074-2340NorvirRitonavir
    0074-3333NorvirRitonavir
    0074-3399NorvirRitonavir
    50090-1162NorvirRitonavir
    53808-1119NorvirRitonavir

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.